Biodesix Inc (BDSX) — Cash Flow-to-Debt Ratio
Biodesix Inc (BDSX) has a Cash Flow-to-Debt Ratio of -0.12x as of March 2026, meaning its operating cash flow of $-10.17 Million could theoretically repay 0% of its total liabilities ($85.50 Million) in one year. Check Biodesix Inc total reinvestment intensity to assess the company's total reinvestment commitment from operating cash flow.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Biodesix Inc Cash Flow-to-Debt Ratio (2018–2025)
Historical debt coverage capacity for Biodesix Inc across 8 annual periods. Also explore balance sheet size of Biodesix Inc for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for Biodesix Inc (2018–2025)
Year-by-year debt coverage analysis for Biodesix Inc. For market capitalisation and broader financial context, see market value of Biodesix Inc.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.26x | $-23.27 Million | $89.94 Million | ▲ +59.4% |
| 2024 | -0.64x | $-48.65 Million | $76.37 Million | ▼ -163.3% |
| 2023 | -0.24x | $-22.87 Million | $94.52 Million | ▲ +61.1% |
| 2022 | -0.62x | $-44.97 Million | $72.30 Million | ▼ -24.2% |
| 2021 | -0.50x | $-28.22 Million | $56.37 Million | ▼ -87.2% |
| 2020 | -0.27x | $-21.37 Million | $79.90 Million | ▼ -232.5% |
| 2019 | -0.08x | $-21.73 Million | $270.17 Million | ▼ -7.9% |
| 2018 | -0.07x | $-17.68 Million | $237.09 Million | — |